Compass Therapeutics (CMPX) Change in Acquisitions & Divestments (2022 - 2026)

Compass Therapeutics' Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $83.3 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 128.68% year-over-year to $83.3 million; the TTM figure through Mar 2026 stood at $148.2 million (up 10.87% YoY), while the FY2025 annual figure was $101.3 million, down 24.97% from the prior year.
• Change in Acquisitions & Divestments came in at $83.3 million for Q1 2026 at Compass Therapeutics, up from $24.1 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $83.3 million in Q1 2026 to a low of $12.8 million in Q3 2022.
• A 5-year average of $36.7 million and a median of $36.2 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments jumped 169.86% in 2023 and slumped 59.52% in 2025, its largest moves.
• Compass Therapeutics' Change in Acquisitions & Divestments stood at $36.2 million in 2022, then surged by 42.01% to $51.4 million in 2023, then slumped by 50.91% to $25.2 million in 2024, then fell by 4.49% to $24.1 million in 2025, then soared by 245.79% to $83.3 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $83.3 million, $24.1 million, and $13.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison